Send feedback

NBN p.Ser40=

c.120G>T · rs774989816 · VCV184454

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 9 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0107%, afr)
Conditions
2
hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.8GERP -5
Overall
CADD3.742PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0107% African / African-American · 8/74,868 alleles
Filtering AF 0.00528% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00381%
Overall 0.00093% 15/1,613,744 alleles · ultra-rare exomes 12/1,461,668 · genomes 3/152,076 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0107% 9,358
Admixed American 0.00667% 14,997
Remaining individualsnot grpmax-eligible 0.0048% 20,823

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NBN
Protein
p.Ser40=
Coding
c.120G>T
MANE Select
NM_002485
dbSNP
rs774989816
Type
single nucleotide variant
Location
chr8:89982773 (GRCh38)
Structure
AlphaFold pLDDT 75.83 · 5 PDB
Full NBN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nbn-p-ser40 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown